African mango (IGOB131): A proprietary seed extract of Irvingia gabonensis is found to be effective in reducing body weight and improving metabolic parameters in overweight humans

Holistic Nursing Practice

Volumn 25, Issue 4, 2011, Pages 215-217

  Ross, Stephanie Maxine ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; DIKANUT; IGOB131; LIPID; PLANT EXTRACT;

ADIPOSE TISSUE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; METABOLISM; OBESITY; PHYTOTHERAPY; PLANT SEED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSE TISSUE; CELLULOSE; DOUBLE-BLIND METHOD; HUMANS; INSULIN RESISTANCE; LIPIDS; OVERWEIGHT; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 79960357744     PISSN: 08879311     EISSN: 15505138     Source Type: Journal    
DOI: 10.1097/HNP.0b013e318222735a     Document Type: Article

References (14)

1. Deen D. Metabolic syndrome: Time for action. Am Fam Physician. 2004;69:2875-2882.
2. Centers for Disease Control and Prevention. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. http://www.cdc.gov/nchs/data/ nhsr/nhsr013.pdf. Accessed, April 16, 2011.
3. Caballero B. Introduction symposium. Obesity in developing countries, biological and ecological factors. J Nutr. 2001;131:866-870.
4. Lee SK, Sobal J. Socio-economic, dietary, activity, nutrition and body weight transitions in South Korea. Public Health Nutr. 2003;6:665-674. (Pubitemid 37314356)
5. Reaven G. Role of insulin resistance in human disease. Diabetes. 1989;37:1595-1607.
6. National Cholesterol Education Program. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (AdultTreatment Panel III) final report. Circulation. 2002;106: 3143-3121.
7. Mandob D, Ngondi J, Fomekong G, Agbor G, Oben J. Prediction and prevalence of metabolic syndrome in overweight and obese subjects in Cameroon. Intern J Biomed Pharm Sci. 2008;2:117-121.
8. Odeku O, Patani B. Evaluation of dika nut mucilage (Irvingia gabonensis) as binding agent in metronidazole tablet formulations. Pharm Devel Technol. 2005;10:439-446. (Pubitemid 41291481)
9. Agbor L. Marketing Trends and Potentials for Irvingia gabonensis Products in Nigeria. Ibidan, Nigeria: ICRAF-II A Conference on Irvingia gabonensis; May 1994.
10. Okolo C, Johnson PB, Abdurahman EM, Abdu-Aguye I, Hussaini IM. Analgesic effect of Irvingia gabonensis stem bark extract. J Ethnopharm. 1995;45(2):125-129.
11. Oben J, Ngondi J, Momo C, et al. The use of Cissus quadrangularis/ Irvingia gabonensis combination in the management of weight loss: A double-blind placebo-controlled study. Lipids Health Dis. 2008;7:12.
12. Ngondi J, Oben J, Minka S. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids Health Dis. 2005;4:12.
13. Ngondi J, Etoundi B, Nyangono C, et al. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis. 2009;8:7.
14. Ngondi JL, Fossouo Z, Djiotsa EJ, Oben J. Glycaemic variations after administration of Irvingia gabonensis seeds fractions in normoglycemic rats. Afri J Trad Cam. 2006;4:94-110.